94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Endocrinol. , 27 September 2024
Sec. Reproduction
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1450375
This article is a correction to:
Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patients
A Corrigendum on
Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patients
By James DW, Quintela M, Lucini L, Alkafri NK, Healey GD, Younas K, Bunkheila A, Margarit L, Francis LW, Gonzalez D, Conlan RS (2024). Front Endocrinol. 15:1368494. doi: 10.3389/fendo.2024.1368494
In the published article, there was an error in the author list, and author Nicholas Jones was erroneously excluded. Author Nour Al Abdullah Al Kafri was incorrectly listed as Noor K. Alkafri. The corrected author list appears below.
“David W. James, Marcos Quintela, Lisa Lucini, Nour Al Abdullah Al Kafri, Gareth D. Healey, Nicholas Jones, Kinza Younas, Adnan Bunkheila, Lavinia Margarit, Lewis W. Francis, Deyarina Gonzalez, R. Steven Conlan”
In the published article, there was an error in the legend for Figure 1 as published. The figure legend included the treatment group cAMP+DHT that is not part of this manuscript. Also, the incorrect dataset and number of patient samples was used.
The corrected legend appears below.
In the published article, there was an error in Figure 1 as published. Wrong dataset and number of patients used. The corrected Figure 1 and its caption “In vitro decidualization” appear below.
Figure 1. In vitro decidualization. Endometrial stromal cells were treated with medium or medium containing cAMP (0.5mM) or cAMP (0.5mM) and MPA (1 x 10-6 M) for 48hrs. Cells were lysed in RLT buffer before storage at -80°C and culture supernatant was collected and stored at -20°C. (A) decidual Prolactin levels of supernatant measured by ELISA in PCOS samples (n=10) vs fertile control (n=8). (B) Quantitative PCR for gene expression of WT1 mRNA normalised to GAPDH. Data presented as mean ± SD; for fertiles (n=8) and PCOS (n=7). Data was analysed by two-way ANOVA and Dunnett’s pairwise multiple comparison test, *p ≤ 0.05.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: WT1, AR, transcription, epigenomics, endometrium, decidualization, polycystic ovary syndrome
Citation: James DW, Quintela M, Lucini L, Al Kafri NAA, Healey GD, Jones N, Younas K, Bunkheila A, Margarit L, Francis LW, Gonzalez D and Conlan RS (2024) Corrigendum: Homeobox regulator Wilms Tumour 1 is displaced by androgen receptor at cis-regulatory elements in the endometrium of PCOS patients. Front. Endocrinol. 15:1450375. doi: 10.3389/fendo.2024.1450375
Received: 17 June 2024; Accepted: 11 September 2024;
Published: 27 September 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 James, Quintela, Lucini, Al Kafri, Healey, Jones, Younas, Bunkheila, Margarit, Francis, Gonzalez and Conlan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: R. Steven Conlan, ci5zLmNvbmxhbkBzd2Fuc2VhLmFjLnVr
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.